Novel polypeptide, dna thereof and use of the same
CA 2460468 C · Owner: Hayashi, Kozo · Inventors: Shimomura, Yukio; Miya, Hiroyuki; Kitada, Chieko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention aims at providing a novel polypeptide a receptor, a, DNA thereof, and the like. Specifically the present invention provides a , polypeptide having a binding ability to the protein represented by SEQ ID NO: 1 or SEQ ID NO: 3, or its amide, its ester or its salt a polynucleotide encoding the , polypeptide an antisense, polynucleotide or an antibody to the polypeptide a screening of agent for , prevention, and/or treatment of cancer obesity, etc. which comprises using the above and the like. The polypeptide, receptor polynucleotide, antisense polynucleotide antibody, and the like are useful for an agent of prevention and/or treatment of cancer obesity and, the like. …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 13, 2002 and granted December 18, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 13, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 13, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.